How wrong you are! Patrys had a solid R&D team who had developed their antibodies over years...they were "in house" personnel all now gone. They also had a dedicated lab in Germany plus personnel in the University dedicated to developing their pipeline...also all now gone.
Patents?? Yes, several of those but take a close look...................
Orphan drug status?? Yes, but only useful if the Abs ever get to market! If PAT-SM6 is not being developed, thenhow is it going to get to the market?
I have said all I am saying on this Company. Time to think about others who have something "real".
Funny trade???, page-18
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.229M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.5¢ | 0.4¢ | $5.431K | 1.357M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 26519870 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 7889760 | 12 |
View Market Depth
| Last trade - 11.23am 15/11/2024 (20 minute delay) ? |
| PAB (ASX) Chart |